S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
Log in
NASDAQ:BLCM

Bellicum Pharmaceuticals SEC Filings & 10K Form

$3.04
+0.01 (+0.33 %)
(As of 11/24/2020 02:49 PM ET)
Add
Compare
Today's Range
$2.94
Now: $3.04
$3.04
50-Day Range
$2.80
MA: $4.85
$6.97
52-Week Range
$2.74
Now: $3.04
$27.90
Volume3,431 shs
Average Volume116,055 shs
Market Capitalization$15.38 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16

SEC Filings

Bellicum Pharmaceuticals (NASDAQ:BLCM) SEC Filings

DateFilerForm TypeView
11/05/2020
3:39 PM
Bellicum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:30 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2020
5:06 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
4:31 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
10/29/2020
4:15 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2020
3:47 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K/A
09/16/2020
3:42 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
4:01 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2020
3:50 PM
Bellicum Pharmaceuticals (Issuer)
Klimovsky Judith V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:49 PM
Bellicum Pharmaceuticals (Issuer)
BROWN JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:47 PM
Bellicum Pharmaceuticals (Issuer)
Huber Reid M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:46 PM
Bellicum Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
8:13 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2020
11:25 AM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2020
2:37 PM
Bellicum Pharmaceuticals (Filer)
Form DEFA14A
04/27/2020
2:34 PM
Bellicum Pharmaceuticals (Filer)
Form DEF 14A
04/16/2020
7:32 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
1:46 PM
Bellicum Pharmaceuticals (Issuer)
Strauss David Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
1:45 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
1:44 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
1:42 PM
Bellicum Pharmaceuticals (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
1:41 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
3:01 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2020
11:48 AM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:48 PM
Bellicum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2020
2:42 PM
ARMISTICE CAPITAL, LLC (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2020
4:29 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2020
4:20 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
1:26 PM
Bellicum Pharmaceuticals (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
1:24 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
1:20 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
12:19 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
12:04 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
4:10 PM
Bellicum Pharmaceuticals (Issuer)
Strauss David Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
3:56 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/24/2020
4:18 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13D/A
01/21/2020
6:59 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2020
3:43 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
4:54 PM
Bellicum Pharmaceuticals (Issuer)
Strauss David Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2020
3:09 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2019
4:15 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
5:10 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
3:13 PM
Bellicum Pharmaceuticals (Filer)
Form DEFA14A
12/05/2019
3:10 PM
Bellicum Pharmaceuticals (Filer)
Form DEF 14A
11/25/2019
3:44 PM
Bellicum Pharmaceuticals (Filer)
Form PRE 14A
11/14/2019
4:11 PM
Bellicum Pharmaceuticals (Issuer)
Woodard Jr Joseph Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:32 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
6:01 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
2:36 PM
Bellicum Pharmaceuticals (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
08/30/2019
3:01 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G
08/26/2019
4:02 PM
Bellicum Pharmaceuticals (Subject)
Boxer Capital, LLC (Filed by)
Form SC 13G
08/23/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:09 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13D
08/19/2019
4:27 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:25 PM
Bellicum Pharmaceuticals (Filer)
Form 424B5
08/16/2019
5:15 AM
Bellicum Pharmaceuticals (Subject)
Form FWP
08/16/2019
5:12 AM
Bellicum Pharmaceuticals (Filer)
Form 424B5
08/15/2019
4:28 PM
Bellicum Pharmaceuticals (Subject)
Form FWP
08/05/2019
3:05 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
8:13 AM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
07/30/2019
11:15 PM
Bellicum Pharmaceuticals (Filer)
Form EFFECT
07/29/2019
7:15 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
3:57 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/23/2019
3:51 PM
Bellicum Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/10/2019
3:25 PM
Bellicum Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
06/24/2019
3:17 PM
Bellicum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/19/2019
3:21 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Klimovsky Judith V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
BROWN JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Bellicum Pharmaceuticals (Issuer)
Huber Reid M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:03 PM
Bellicum Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Woodard Jr Joseph Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Williams Rosemary Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:58 PM
Bellicum Pharmaceuticals (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Smith Alan K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:57 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
8:06 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
8:02 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:05 PM
Bellicum Pharmaceuticals (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:06 PM
Bellicum Pharmaceuticals (Filer)
Form DEFA14A
05/07/2019
3:32 PM
Bellicum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:24 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
2:43 PM
Bellicum Pharmaceuticals (Filer)
Form DEF 14A
04/12/2019
4:16 PM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
04/10/2019
3:10 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2019
8:01 AM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:25 PM
Bellicum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:05 PM
Bellicum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
3:01 PM
Bellicum Pharmaceuticals (Issuer)
Foster Aaron E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2019
9:11 AM
Bellicum Pharmaceuticals (Filer)
Form CT ORDER
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Bellicum Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2019
3:02 PM
Bellicum Pharmaceuticals (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:12 PM
Bellicum Pharmaceuticals (Issuer)
Naeve Gregory S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.